News
The US FDA has approved Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When...
Read more
Dr. Reddy’s Laboratories Ltd announced that it has launched Nystatin and Triamcinolone Acetonide Cream, USP, in the United States market,...
Read more
Novelion Therapeutics, Inc announced that its subsidiary, Aegerion Pharmaceuticals Inc has entered into a licensing agreement with Amryt Pharma for...
Read moreAs part of the 2016 Radiological Society of North America Annual Meeting (RSNA), Royal Philips announced the introduction of IntelliSpace...
Read moreAbsorption Systems, a world leader in novel test systems for drug transporters, announces the renewal of a technology licensing deal...
Read moreEgalet Corporation a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other...
Read moreViiV Healthcare presented 48-week data from the phase IIIb, open-label, international, multi-centre ARIA study which showed superior efficacy for Triumeq...
Read moreAllergan plc announced that it has filed with the U.S. FDA the de novo application for the Oculeve Intranasal Tear...
Read moreMerck, a leading science and technology company announced that the EMA to request the company for marketing approval for its...
Read moreThe Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the...
Read more
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.